Suvorexant and Sleep/Delirium in ICU Patients

Conditions:   Insomnia;   Sleep Fragmentation;   Sleep Initiation and Maintenance Disorders;   Postoperative Delirium Interventions:   Drug: Suvorexant 20 mg;   Drug: Placebo oral tablet Sponsors:   Beth Israel Deaconess Medical Center;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials